Literature DB >> 1083556

Demonstration of T lymphocytes in cerebrospinal fluid.

A Naess.   

Abstract

Cerebrospinal fluid (CSF) was allowed to drop straight into Hanks's balanced salt solution. After centrifugation the pellet was resuspended and mixed with sheep erythrocytes. The mixture was further handled as in the E-rosette test with peripheral blood lymphocytes. CSF from 20 individuals were investigated, and rosette-forming cells (RFC) were found in all. Six patients with normal fluid had between 46% and 83% RFC. Four patients with multiple sclerosis had increased numbers of RFC (94%-96%). Low numbers of RFC were found in one patient with cerebellar ataxia and in one of two patients with acute viral meningitis. With this technique RFC can be counted even in normal CSF with a 3-ml sample.

Entities:  

Mesh:

Year:  1976        PMID: 1083556     DOI: 10.1111/j.1365-3083.1976.tb03004.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  5 in total

1.  Lymphocytic infiltration of the brain in sleeping sickness.

Authors:  B M Greenwood; H C Whittle; K O Oduloju; R R Dourmashkin
Journal:  Br Med J       Date:  1976-11-27

2.  A practicable method for the analysis of T lymphocyte subsets in CSF lymphopleocytosis.

Authors:  R Hohlfeld; A Schwartz; U Brocke; K V Toyka
Journal:  Klin Wochenschr       Date:  1983-09-15

3.  Immunocytochemical identification and quantitation of the mononuclear cells in the cerebrospinal fluid, meninges, and brain during acute viral meningoencephalitis.

Authors:  T R Moench; D E Griffin
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

4.  Investigations on blood and cerebrospinal fluid lymphocytes in patients suffering from tick-borne encephalitis.

Authors:  J Sipos; P Ribiczey; V Gábor; Z Tóth; K Bartók
Journal:  Infection       Date:  1981       Impact factor: 3.553

5.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.